Acadia Healthcare Company, Inc. (ACHC)

NASDAQ: ACHC · USD

$29.6

-0.27 (-0.9%)· Recorded snapshot

Market cap	2.8B
Revenue (ttm)	3.4B
Net income (ttm)	-1.1B
EPS (ttm)	-$12.4
Shares out	93.1M
P/E (forward)	17.4x
Volume	1,616,309
Beta	0.63

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.4B
Net income (ttm): -1.1B
EPS (ttm): -$12.4
P/E (forward): 17.4x
Market cap: 2.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-41.4

P25 n/aP50 n/aP75 n/a

ROIC7.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ACHC indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001520697
Company name	Acadia Healthcare Company, Inc.
Country	United States
Country code	US
CUSIP number	00404A109
Earnings date	2026-11-04
Earnings time	amc
Employees	25,000
Employees change	-500
Employees growth	-1.96%
Enterprise value	$5.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
In index	RUSSELL2000
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US00404A1097
Last 10-K release date	2026-02-27
Last earnings date	2026-07-28
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.8B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$29.63
Price currency	USD
Sector	Healthcare
SIC code	8093
Stock price date	2026-10-28
Symbol	ACHC
U.S. state	Tennessee
Website	https://www.acadiahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	19.24x
Earnings yield	-42%
EV/EBIT	15.32x
EV/EBITDA	9.71x
EV/Sales	1.54x
FCF / EV yield	-2.58%
FCF yield	-4.83%
Forward EV/Sales	1.47x
Forward P/E	17.39x
Forward P/S	0.79x
Industry forward P/E	15.38x
Industry P/E	18.76x
P/(OCF - SBC) ratio	15.49x
P/B ratio	1.37x
P/OCF ratio	13.18x
P/S ratio	0.82x
Price / tangible book value	4.82x
Price/EBITDA ratio	5.19x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.06%
EBITDA margin	15.88%
Gross margin	41.06%
Operating margin	10.06%
Pretax margin	-32.56%
Profit margin	-33.44%
Profit per employee	$-45,050
Profitable quarters	2
Revenue per employee	$134,707
ROA	3.57%
ROA (5Y)	5.25%
ROCE	6.76%
ROE	-41.44%
ROE (5Y)	-2.68%
ROIC	7.28%
ROIC (5Y)	8.54%
SBC / revenue	0.93%
Tax / revenue	0.76%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-63.64%
EPS growth (QoQ)	164.64%
EPS growth years	0
Gross profit growth	1.43%
Gross profit growth (Q)	-6.89%
Gross profit growth 3Y	5.49%
Gross profit growth 5Y	8.28%
Net income growth (Q)	-63.73%
Net income growth (QoQ)	166.21%
Net income growth years	0
OCF growth	-50.45%
OCF growth (Q)	21.4%
OCF growth (QoQ)	163.39%
OCF growth 10Y	-4.46%
OCF growth 3Y	-16.59%
OCF growth 5Y	-17.78%
Operating income growth	-28.14%
Operating income growth (Q)	-38.32%
Operating income growth 3Y	-10.54%
Operating income growth 5Y	-2.9%
Revenue growth	4.28%
Revenue growth (Q)	-0.39%
Revenue growth (QoQ)	4.47%
Revenue growth 10Y	3.67%
Revenue growth 3Y	6.63%
Revenue growth 5Y	8.67%
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-344.5M
Depreciation and amortization	$196.1M
EBIT	$338.8M
EBITDA	$534.8M
EPS	$-12.44
FCF per share	$-1.44
Financing cash flow	$144.4M
Free cash flow	$-134M
Free cash flow minus SBC	$-165.5M
Gross profit	$1.4B
Income taxes	$25.8M
Investing cash flow	$-315.1M
Net borrowing	$143.7M
Net cash flow	$39.9M
Net income	$-1.1B
Operating cash flow minus SBC	$179.1M
Operating income	$338.8M
Revenue	$3.4B
Stock-based compensation	$31.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.04
Book value per share	$21.78
Debt / EBITDA	4.44
Debt / equity	1.18
Goodwill	$1.3B
Interest coverage	2.24
Long-term assets	$4.7B
Long-term liabilities	$2.8B
Net cash (debt)	$-2.4B
Net cash / market cap	-87.09%
Net debt / EBITDA	4.52
Net debt / equity	1.1
Piotroski F-Score	5
Property, plant and equipment	$3.2B
Shareholders' equity	$2.2B
Tangible book value	$575.7M
Tangible book value per share	$6.34
Total assets	$5.5B
Total cash	$171.3M
Total debt	$2.6B
Total liabilities	$3.4B
WACC	6.2%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	$845.3M
Current liabilities	$537.6M
Current ratio	1.57
Inventory turnover	328.64
Net working capital	$190.8M
Quick ratio	1.35
Working capital	$307.7M
Working capital turnover	14.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.29%
Dividend yield	0%
Shareholder yield	1.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-19.83%
10Y return CAGR	-2.19%
10Y total return	-19.83%
150-day SMA	$28.06
1D price change	-0.9%
1M price change	5.48%
1M total return	5.48%
1W price change	-5.73%
1W total return	-5.73%
1Y price change	29.11%
1Y return CAGR	29.13%
1Y total return	29.11%
20-day SMA	$30.01
200-day SMA	$25.62
3M price change	-8.83%
3M total return	-8.83%
3Y price change	-58.86%
3Y return CAGR	-25.62%
3Y total return	-58.86%
50-day SMA	$28.98
50-day SMA vs 200-day SMA	50over200
52-week high	$35.83
52-week high date	2026-07-22
52-week low	$11.43
52-week low date	2026-01-15
5Y price change	-47.2%
5Y return CAGR	-11.99%
5Y total return	-47.2%
6M price change	5.26%
6M total return	5.26%
All-time high	$89.85
All-time high date	2022-11-30
All-time low	$5.43
All-time low date	2011-12-06
Average true range (ATR)	$1.29
Average volume	1.4M
Beta (1Y)	0.12
Beta (2Y)	0.62
Beta (5Y)	0.63
Change from 52-week high	-17.3%
Change from 52-week low	159.23%
Change from all-time high	-67.02%
Change from all-time low	445.67%
Change from open	-0.84%
Day's gap	-0.07%
Dollar volume	$47.9M
High price	$30.46
Low price	$29.29
Monthly RSI	46.15
Open price	$29.88
Position in 52-week range	29.06%
Premarket change	0%
Premarket close	$29.90
Premarket price	$29.90
Previous close	$29.90
Price vs 150-day SMA	5.58%
Price vs 20-day SMA	-1.26%
Price vs 200-day SMA	15.67%
Price vs 50-day SMA	2.23%
Relative volume	1.14
RSI	48.13
Sharpe ratio	0.65
Sharpe ratio (3Y)	-0.35
Sharpe ratio (5Y)	-0.12
Sortino ratio	1.09
Sortino ratio (3Y)	-0.38
Sortino ratio (5Y)	-0.05
Volume	1.6M
Weekly RSI	55.32
YTD price change	108.81%
YTD total return	108.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	91.5M
Float percentage	98.31%
Shares change (QoQ)	0.57%
Shares change (YoY)	-1.29%
Shares held by insiders	1.66%
Shares held by institutions	145.28%
Shares outstanding	93.1M
Short % of float	24.88%
Short % of shares	24.46%
Short ratio	15.7 days

Deeper analysis on ACHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ACHC report

Is a complete ACHC research report available?

No complete published report is available for Acadia Healthcare Company, Inc. (ACHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Acadia Healthcare Company, Inc. (ACHC)

Price

Financial snapshot

Fair-value bridge

Latest news · ACHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ACHC

Frequently asked questions